Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon alfa-2b and ribavirin for liver fibrosis in chronic hepatitis C
NCT00323804Phase 3Completed
- Sponsor
- ANRS
- Start
- May 2006
- Primary completion
- Feb 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 3 trial of ribavirin in Liver Fibrosis (LF), hepatitis C virus infection, sponsored by ANRS. Started May 2006; status: completed.
02
Drugs
ribavirin
03
Conditions
Liver Fibrosis (LF)hepatitis C virus infection
Beyond the preview
Go deeper on NCT00323804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323804.